Sage Therapeutics Inc
(NAS:SAGE)
$
12
0.5 (4.35%)
Market Cap: 722.18 Mil
Enterprise Value: 8.48 Mil
PE Ratio: 0
PB Ratio: 1.02
GF Score: 46/100 - Q1 2024 SAGE Therapeutics Inc Earnings Call TranscriptApr 25, 2024$13.58 (-3.00%)Earnings
- Q4 2023 SAGE Therapeutics Inc Earnings Call TranscriptFeb 14, 2024$25.75 (+11.86%)Earnings
- SAGE Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 SAGE Therapeutics Inc Earnings Call TranscriptNov 07, 2023$19.63 (-4.75%)Earnings
- SAGE Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 SAGE Therapeutics Inc Earnings Call TranscriptAug 07, 2023$16.75 (-53.60%)Earnings
- SAGE Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- SAGE Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- SAGE Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 SAGE Therapeutics Inc Earnings Call TranscriptMay 02, 2023$45.55 (-6.35%)Earnings
- SAGE Therapeutics Inc at Stifel CNS Days (Virtual) TranscriptMar 29, 2023
- SAGE Therapeutics Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Q4 2022 SAGE Therapeutics Inc Earnings Call TranscriptFeb 16, 2023$45.06 (-0.11%)Earnings
- SAGE Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone TranscriptDec 06, 2022
- SAGE Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Q3 2022 SAGE Therapeutics Inc Earnings Call TranscriptNov 08, 2022$33.91 (+0.09%)Earnings
- SAGE Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 SAGE Therapeutics Inc Earnings Call TranscriptAug 02, 2022$35.25 (+2.32%)Earnings
- SAGE Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- SAGE Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2022
- SAGE Therapeutics Inc SKYLARK Study Topline Data Call TranscriptJun 01, 2022
- SAGE Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 SAGE Therapeutics Inc Earnings Call TranscriptMay 03, 2022$32.79 (+0.58%)Earnings
- SAGE Therapeutics Inc at Stifel CNS Days (Virtual) TranscriptMar 29, 2022
- SAGE Therapeutics Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 SAGE Therapeutics Inc Earnings Call TranscriptFeb 24, 2022$34.71 (+6.44%)Earnings
- SAGE Therapeutics Inc CORAL Study Topline Results Conference Call TranscriptFeb 16, 2022
- SAGE Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- SAGE Therapeutics Inc FutureCast: An R&D and Portfolio Review TranscriptDec 14, 2021
- SAGE Therapeutics Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 01, 2021
- SAGE Therapeutics Inc at Stifel Healthcare Conference (Virtual) TranscriptNov 15, 2021
- Q3 2021 SAGE Therapeutics Inc Earnings Call TranscriptNov 02, 2021$43.57 (+2.83%)Earnings
- SAGE Therapeutics Inc Corporate Call - ECNP Encore Presentation: Zuranolone Data Review TranscriptOct 04, 2021
- SAGE Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- SAGE Therapeutics Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 11, 2021
- SAGE Therapeutics Inc at Wedbush PacGrow Healthcare Conference (Virtual) TranscriptAug 10, 2021
- Q2 2021 SAGE Therapeutics Inc Earnings Call TranscriptAug 03, 2021$41.76 (-3.71%)Earnings
- SAGE Therapeutics Inc at Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit (Virtual) TranscriptJul 13, 2021
- SAGE Therapeutics Inc at SVB Leerink CNS Forum (Virtual) TranscriptJun 29, 2021
- SAGE Therapeutics Inc to Review Topline Results from the Phase 3 WATERFALL Study Call TranscriptJun 15, 2021
- SAGE Therapeutics Inc to Host Sage Science Spotlight: SAGE-718 In Depth TranscriptMay 20, 2021
- SAGE Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- SAGE Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 SAGE Therapeutics Inc Earnings Call TranscriptMay 04, 2021$71.14 (-9.90%)Earnings
- SAGE Therapeutics Inc KINETIC Study Topline Results Conference Call TranscriptApr 12, 2021
- SAGE Therapeutics Inc at Stifel CNS Day TranscriptMar 31, 2021
- SAGE Therapeutics Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- SAGE Therapeutics Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 SAGE Therapeutics Inc Earnings Call TranscriptFeb 24, 2021$85.04 (+5.98%)Earnings
- SAGE Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- SAGE Therapeutics Inc at BMO Capital Markets Growth & ESG Conference (Virtual) TranscriptDec 09, 2020
- Biogen Inc Conference Call to Discuss Collaboration with SAGE Therapeutics Inc TranscriptNov 30, 2020
- SAGE Therapeutics Inc Conference Call to Discuss Collaboration with Biogen Inc TranscriptNov 30, 2020
- SAGE Therapeutics Inc at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 19, 2020
- SAGE Therapeutics Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- Q3 2020 SAGE Therapeutics Inc Earnings Call TranscriptNov 05, 2020$78.11 (-0.56%)Earnings
- SAGE Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- SAGE Therapeutics Inc Sage FutureCast: An R&D and Portfolio Review TranscriptSep 10, 2020
- SAGE Therapeutics Inc at Wedbush PacGrow Healthcare Virtual Conference TranscriptAug 12, 2020
- Q2 2020 SAGE Therapeutics Inc Earnings Call TranscriptAug 10, 2020$53.31 (+5.15%)Earnings
- Sage Therapeutics, Inc. Presents at Goldman Sachs 41st Annual Global Healthcare Conference, Jun-10-2020 12:00 PM TranscriptJun 10, 2020
- SAGE Therapeutics Inc Annual Shareholders Meeting TranscriptJun 09, 2020
- Sage Therapeutics, Inc. Presents at BofA Securities 2020 Health Care Conference, May-13-2020 01:40 PM TranscriptMay 13, 2020
- Q1 2020 SAGE Therapeutics Inc Earnings Call TranscriptMay 07, 2020$40.76 (-0.27%)Earnings
- SAGE Therapeutics Inc Conference Call TranscriptApr 07, 2020
- SAGE Therapeutics Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 SAGE Therapeutics Inc Earnings Call TranscriptFeb 27, 2020$52.01 (-18.29%)Earnings
- SAGE Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Sage Therapeutics, Inc. - Special Call TranscriptDec 05, 2019
- SAGE Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 19, 2019
- Q3 2019 SAGE Therapeutics Inc Earnings Call TranscriptNov 12, 2019$141.55 (-1.93%)Earnings
- SAGE Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 SAGE Therapeutics Inc Earnings Call TranscriptAug 06, 2019$162.34 (+3.64%)Earnings
- Sage Therapeutics, Inc. - Special Call TranscriptJul 24, 2019
- SAGE Therapeutics Inc at BMO Capital Markets Prescription for Success Healthcare Conference TranscriptJun 25, 2019
- SAGE Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- SAGE Therapeutics Inc at RBC Capital Markets Healthcare Conference TranscriptMay 21, 2019
- SAGE Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 SAGE Therapeutics Inc Earnings Call TranscriptMay 02, 2019$165.52 (-0.74%)Earnings
- Q4 2018 SAGE Therapeutics Inc Earnings Call TranscriptFeb 19, 2019Earnings
SAGE Therapeutics Inc at RBC Capital Markets Healthcare Conference Transcript
May 21, 2019 / 07:35PM GMT
Release Date Price:
$171.03
(+4.66%)
Brian Corey Abrahams
RBC Capital Markets, LLC, Research Division - Senior Analyst
Everyone, I'm Brian Abrahams, one of the senior biotech analysts here at RBC Capital Markets. Our next presenting company is Sage Therapeutics, represented by their CFO, Kimi Iguchi; and their Chief Research Officer, Jim Doherty. Thanks guys for joining us.
Jim Doherty
Sage Therapeutics, Inc. - Chief Research Officer
Thanks for having us.
Kimi E. Iguchi
Sage Therapeutics, Inc. - CFO & Treasurer
Thank you.
Questions & Answers
Brian Corey Abrahams
RBC Capital Markets, LLC, Research Division - Senior Analyst
So maybe we should start on the commercial front, and the brexanolone or ZULRESSO upcoming launch. Drug was just approved a couple of months ago so congratulations on your first drug approval. Where do you guys stand with respect to launch preparations and timelines there?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)